Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of KW-3357 in early-onset severe preeclampsia
jRCT2080224912Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Oct 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preeclampsia comparing KW-3357 with Placebo (2 arms). Started Oct 2019; status: completed.
02
Drugs
antithrombin gamma
03
Conditions
preeclampsia
Beyond the preview
Go deeper on jRCT2080224912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224912.